nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—CYP3A4—chronic kidney failure	0.418	0.546	CbGaD
Tolvaptan—ABCB1—chronic kidney failure	0.348	0.454	CbGaD
Tolvaptan—AVPR2—nephron—chronic kidney failure	0.0258	0.342	CbGeAlD
Tolvaptan—AVPR2—urine—chronic kidney failure	0.0207	0.275	CbGeAlD
Tolvaptan—AVPR2—nephron tubule—chronic kidney failure	0.00558	0.0739	CbGeAlD
Tolvaptan—AVPR2—renal system—chronic kidney failure	0.00507	0.0672	CbGeAlD
Tolvaptan—AVPR2—kidney—chronic kidney failure	0.0049	0.065	CbGeAlD
Tolvaptan—CYP3A4—urine—chronic kidney failure	0.00315	0.0418	CbGeAlD
Tolvaptan—CYP3A4—blood plasma—chronic kidney failure	0.00165	0.0218	CbGeAlD
Tolvaptan—Zafirlukast—PTGS1—chronic kidney failure	0.00147	0.182	CrCbGaD
Tolvaptan—Zafirlukast—CYP2C19—chronic kidney failure	0.00135	0.167	CrCbGaD
Tolvaptan—Conivaptan—CYP3A4—chronic kidney failure	0.00128	0.159	CrCbGaD
Tolvaptan—ABCB1—blood plasma—chronic kidney failure	0.00117	0.0154	CbGeAlD
Tolvaptan—Vismodegib—CYP2C19—chronic kidney failure	0.00114	0.142	CrCbGaD
Tolvaptan—Zafirlukast—CYP3A4—chronic kidney failure	0.000856	0.106	CrCbGaD
Tolvaptan—CYP3A4—renal system—chronic kidney failure	0.000772	0.0102	CbGeAlD
Tolvaptan—CYP3A4—kidney—chronic kidney failure	0.000746	0.00989	CbGeAlD
Tolvaptan—Vismodegib—CYP3A4—chronic kidney failure	0.000725	0.09	CrCbGaD
Tolvaptan—CYP3A4—digestive system—chronic kidney failure	0.000633	0.00839	CbGeAlD
Tolvaptan—Vismodegib—ALB—chronic kidney failure	0.000633	0.0785	CrCbGaD
Tolvaptan—Vismodegib—ABCB1—chronic kidney failure	0.000604	0.075	CrCbGaD
Tolvaptan—CYP3A4—blood—chronic kidney failure	0.000603	0.00799	CbGeAlD
Tolvaptan—ABCB1—nephron tubule—chronic kidney failure	0.000601	0.00797	CbGeAlD
Tolvaptan—ABCB1—renal system—chronic kidney failure	0.000546	0.00724	CbGeAlD
Tolvaptan—ABCB1—cardiovascular system—chronic kidney failure	0.00054	0.00715	CbGeAlD
Tolvaptan—ABCB1—urethra—chronic kidney failure	0.000537	0.00711	CbGeAlD
Tolvaptan—ABCB1—kidney—chronic kidney failure	0.000528	0.007	CbGeAlD
Tolvaptan—ABCB1—cortex of kidney—chronic kidney failure	0.000514	0.00682	CbGeAlD
Tolvaptan—ABCB1—gonad—chronic kidney failure	0.00049	0.00649	CbGeAlD
Tolvaptan—ABCB1—digestive system—chronic kidney failure	0.000448	0.00594	CbGeAlD
Tolvaptan—ABCB1—blood—chronic kidney failure	0.000427	0.00566	CbGeAlD
Tolvaptan—AVPR1A—GPCR downstream signaling—DRD1—chronic kidney failure	0.000184	0.00122	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TFDP2—chronic kidney failure	0.000183	0.00121	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—DRD1—chronic kidney failure	0.000183	0.00121	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TFDP2—chronic kidney failure	0.000182	0.0012	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CRH—chronic kidney failure	0.00018	0.00119	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—OXT—chronic kidney failure	0.00018	0.00119	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIP5K1B—chronic kidney failure	0.000179	0.00119	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	0.000179	0.00118	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—OXT—chronic kidney failure	0.000179	0.00118	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CRH—chronic kidney failure	0.000179	0.00118	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIP5K1B—chronic kidney failure	0.000178	0.00118	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—chronic kidney failure	0.000177	0.00117	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—F2—chronic kidney failure	0.000176	0.00116	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—F2—chronic kidney failure	0.000174	0.00115	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—NPS—chronic kidney failure	0.000171	0.00113	CbGpPWpGaD
Tolvaptan—CYP3A4—Tryptophan metabolism—CAT—chronic kidney failure	0.00017	0.00112	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—NPS—chronic kidney failure	0.00017	0.00112	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—chronic kidney failure	0.000169	0.00112	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—DRD1—chronic kidney failure	0.000167	0.00111	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—DRD1—chronic kidney failure	0.000166	0.0011	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PGF—chronic kidney failure	0.000163	0.00108	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PGF—chronic kidney failure	0.000162	0.00107	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—POMC—chronic kidney failure	0.00016	0.00106	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—POMC—chronic kidney failure	0.000159	0.00105	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CCL2—chronic kidney failure	0.000156	0.00103	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CCL2—chronic kidney failure	0.000155	0.00103	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—chronic kidney failure	0.000155	0.00102	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PRKAG2—chronic kidney failure	0.000154	0.00102	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PRKAG2—chronic kidney failure	0.000152	0.00101	CbGpPWpGaD
Tolvaptan—CYP3A4—Tryptophan metabolism—CYP1A1—chronic kidney failure	0.000152	0.00101	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—chronic kidney failure	0.000151	0.001	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—PPARA—chronic kidney failure	0.000151	0.000997	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—COL4A3—chronic kidney failure	0.000146	0.000963	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—COL4A3—chronic kidney failure	0.000145	0.000956	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—chronic kidney failure	0.000143	0.000943	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HBEGF—chronic kidney failure	0.000142	0.000942	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HBEGF—chronic kidney failure	0.000141	0.000935	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CRHR1—chronic kidney failure	0.000139	0.000918	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CRHR1—chronic kidney failure	0.000138	0.000912	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AVP—chronic kidney failure	0.000136	0.000899	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AVP—chronic kidney failure	0.000135	0.000893	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LRP2—chronic kidney failure	0.000133	0.00088	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LRP2—chronic kidney failure	0.000132	0.000874	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—EDN1—chronic kidney failure	0.000129	0.000855	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—EDN1—chronic kidney failure	0.000128	0.000849	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CCL5—chronic kidney failure	0.000128	0.000849	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CCL5—chronic kidney failure	0.000127	0.000843	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTH—chronic kidney failure	0.000127	0.00084	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTH—chronic kidney failure	0.000126	0.000834	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic kidney failure	0.000126	0.000833	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP2B6—chronic kidney failure	0.000125	0.000827	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CYBB—chronic kidney failure	0.000124	0.000819	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AVP—chronic kidney failure	0.000123	0.000817	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP2B6—chronic kidney failure	0.000123	0.000816	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic kidney failure	0.000123	0.000815	CbGpPWpGaD
Tolvaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic kidney failure	0.000123	0.000814	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CYBB—chronic kidney failure	0.000123	0.000813	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AVP—chronic kidney failure	0.000123	0.000811	CbGpPWpGaD
Tolvaptan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic kidney failure	0.000121	0.000803	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—EDN1—chronic kidney failure	0.000117	0.000777	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FGF23—chronic kidney failure	0.000117	0.000775	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—EDN1—chronic kidney failure	0.000117	0.000771	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL5—chronic kidney failure	0.000117	0.000771	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FGF23—chronic kidney failure	0.000116	0.00077	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL5—chronic kidney failure	0.000116	0.000765	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CCR5—chronic kidney failure	0.000116	0.000765	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CCR5—chronic kidney failure	0.000115	0.000759	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ALB—chronic kidney failure	0.000112	0.000741	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC34A1—chronic kidney failure	0.000112	0.00074	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NPY—chronic kidney failure	0.00011	0.00073	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NPY—chronic kidney failure	0.00011	0.000724	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP2C18—chronic kidney failure	0.000108	0.000717	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP2C18—chronic kidney failure	0.000107	0.000708	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CRH—chronic kidney failure	0.000106	0.000704	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—OXT—chronic kidney failure	0.000106	0.000704	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—OXT—chronic kidney failure	0.000106	0.000699	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CRH—chronic kidney failure	0.000106	0.000699	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCR5—chronic kidney failure	0.000105	0.000694	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCR5—chronic kidney failure	0.000104	0.000689	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NCF1—chronic kidney failure	0.000102	0.000674	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NCF1—chronic kidney failure	0.000101	0.000669	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NPS—chronic kidney failure	0.000101	0.000667	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NPS—chronic kidney failure	0.0001	0.000662	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic kidney failure	9.97e-05	0.00066	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—F2—chronic kidney failure	9.92e-05	0.000656	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—DRD1—chronic kidney failure	9.89e-05	0.000654	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—F2—chronic kidney failure	9.85e-05	0.000651	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—DRD1—chronic kidney failure	9.82e-05	0.00065	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CYBA—chronic kidney failure	9.58e-05	0.000634	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC22A2—chronic kidney failure	9.52e-05	0.000629	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CYBA—chronic kidney failure	9.51e-05	0.000629	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC7A9—chronic kidney failure	9.27e-05	0.000613	CbGpPWpGaD
Tolvaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—chronic kidney failure	9.17e-05	0.000607	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—POMC—chronic kidney failure	9.04e-05	0.000598	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—F2—chronic kidney failure	9.01e-05	0.000596	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP2C19—chronic kidney failure	8.99e-05	0.000594	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—POMC—chronic kidney failure	8.97e-05	0.000593	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—F2—chronic kidney failure	8.94e-05	0.000591	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL1B—chronic kidney failure	8.86e-05	0.000586	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP2C19—chronic kidney failure	8.86e-05	0.000586	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ABCG1—chronic kidney failure	8.85e-05	0.000585	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic kidney failure	8.67e-05	0.000573	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HBEGF—chronic kidney failure	8.41e-05	0.000556	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HBEGF—chronic kidney failure	8.35e-05	0.000552	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—PTGS1—chronic kidney failure	8.22e-05	0.000544	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—POMC—chronic kidney failure	8.21e-05	0.000543	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC6A13—chronic kidney failure	8.17e-05	0.00054	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—POMC—chronic kidney failure	8.15e-05	0.000539	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL2—chronic kidney failure	8.03e-05	0.000531	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL2—chronic kidney failure	7.97e-05	0.000527	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—VEGFA—chronic kidney failure	7.51e-05	0.000496	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	7.44e-05	0.000492	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AVP—chronic kidney failure	7.29e-05	0.000482	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AVP—chronic kidney failure	7.24e-05	0.000479	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EDN1—chronic kidney failure	6.94e-05	0.000459	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TGFB1—chronic kidney failure	6.89e-05	0.000456	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EDN1—chronic kidney failure	6.89e-05	0.000456	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL5—chronic kidney failure	6.88e-05	0.000455	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL5—chronic kidney failure	6.83e-05	0.000452	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LPL—chronic kidney failure	6.73e-05	0.000445	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—GCKR—chronic kidney failure	6.71e-05	0.000443	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ABCC3—chronic kidney failure	6.71e-05	0.000443	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LPL—chronic kidney failure	6.68e-05	0.000442	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—chronic kidney failure	6.43e-05	0.000425	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ABCC2—chronic kidney failure	6.43e-05	0.000425	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NGF—chronic kidney failure	6.38e-05	0.000422	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NGF—chronic kidney failure	6.33e-05	0.000419	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCR5—chronic kidney failure	6.2e-05	0.00041	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCR5—chronic kidney failure	6.16e-05	0.000407	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—FABP1—chronic kidney failure	6.05e-05	0.0004	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AGXT—chronic kidney failure	5.73e-05	0.000379	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GATM—chronic kidney failure	5.73e-05	0.000379	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—chronic kidney failure	5.67e-05	0.000375	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—F2—chronic kidney failure	5.32e-05	0.000352	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP1A1—chronic kidney failure	5.3e-05	0.00035	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—F2—chronic kidney failure	5.28e-05	0.000349	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ACAT1—chronic kidney failure	5.24e-05	0.000347	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP1A1—chronic kidney failure	5.22e-05	0.000346	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IRS1—chronic kidney failure	5.03e-05	0.000333	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IRS1—chronic kidney failure	5e-05	0.000331	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MLXIPL—chronic kidney failure	4.87e-05	0.000322	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—POMC—chronic kidney failure	4.85e-05	0.000321	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—POMC—chronic kidney failure	4.81e-05	0.000318	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL2—chronic kidney failure	4.74e-05	0.000314	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL2—chronic kidney failure	4.71e-05	0.000311	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—chronic kidney failure	4.7e-05	0.000311	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF1—chronic kidney failure	4.66e-05	0.000308	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF1—chronic kidney failure	4.63e-05	0.000306	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC22A2—chronic kidney failure	4.46e-05	0.000295	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SERPINE1—chronic kidney failure	4.43e-05	0.000293	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SERPINE1—chronic kidney failure	4.4e-05	0.000291	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—KRAS—chronic kidney failure	4.38e-05	0.00029	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—KRAS—chronic kidney failure	4.35e-05	0.000288	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOS3—chronic kidney failure	4.23e-05	0.00028	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOS3—chronic kidney failure	4.2e-05	0.000278	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCG1—chronic kidney failure	4.14e-05	0.000274	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—chronic kidney failure	4.08e-05	0.00027	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIP5K1B—chronic kidney failure	4.06e-05	0.000268	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RELA—chronic kidney failure	3.98e-05	0.000263	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ARG2—chronic kidney failure	3.97e-05	0.000263	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RELA—chronic kidney failure	3.95e-05	0.000261	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—POMC—chronic kidney failure	3.95e-05	0.000261	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LCAT—chronic kidney failure	3.9e-05	0.000258	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—FABP1—chronic kidney failure	3.73e-05	0.000246	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic kidney failure	3.7e-05	0.000245	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—DDC—chronic kidney failure	3.58e-05	0.000237	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—chronic kidney failure	3.57e-05	0.000236	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—chronic kidney failure	3.54e-05	0.000234	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GATM—chronic kidney failure	3.53e-05	0.000234	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AGXT—chronic kidney failure	3.53e-05	0.000234	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—AVP—chronic kidney failure	3.52e-05	0.000233	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2B6—chronic kidney failure	3.47e-05	0.00023	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PRKAG2—chronic kidney failure	3.47e-05	0.00023	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PRKD1—chronic kidney failure	3.47e-05	0.00023	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic kidney failure	3.4e-05	0.000225	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NFKB1—chronic kidney failure	3.36e-05	0.000222	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NFKB1—chronic kidney failure	3.33e-05	0.00022	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SREBF2—chronic kidney failure	3.25e-05	0.000215	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ACAT1—chronic kidney failure	3.23e-05	0.000214	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic kidney failure	3.17e-05	0.00021	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—chronic kidney failure	3.15e-05	0.000208	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GCKR—chronic kidney failure	3.14e-05	0.000208	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCC3—chronic kidney failure	3.14e-05	0.000208	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LPIN1—chronic kidney failure	3.07e-05	0.000203	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—chronic kidney failure	3.05e-05	0.000201	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—chronic kidney failure	3.02e-05	0.0002	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LRP2—chronic kidney failure	3.01e-05	0.000199	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2C18—chronic kidney failure	3.01e-05	0.000199	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MLXIPL—chronic kidney failure	3e-05	0.000199	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—PPARA—chronic kidney failure	2.87e-05	0.00019	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TGFB1—chronic kidney failure	2.8e-05	0.000185	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TGFB1—chronic kidney failure	2.78e-05	0.000184	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC22A2—chronic kidney failure	2.75e-05	0.000182	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KRAS—chronic kidney failure	2.59e-05	0.000171	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KRAS—chronic kidney failure	2.57e-05	0.00017	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CPT1A—chronic kidney failure	2.56e-05	0.000169	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCG1—chronic kidney failure	2.55e-05	0.000169	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	2.5e-05	0.000165	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2C19—chronic kidney failure	2.49e-05	0.000165	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LIPC—chronic kidney failure	2.49e-05	0.000165	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ARG2—chronic kidney failure	2.45e-05	0.000162	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LCAT—chronic kidney failure	2.4e-05	0.000159	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SCARB1—chronic kidney failure	2.31e-05	0.000152	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS1—chronic kidney failure	2.28e-05	0.000151	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SREBF1—chronic kidney failure	2.24e-05	0.000148	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—DDC—chronic kidney failure	2.2e-05	0.000146	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMGCR—chronic kidney failure	2.18e-05	0.000144	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	2.14e-05	0.000142	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	2.14e-05	0.000142	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PRKD1—chronic kidney failure	2.14e-05	0.000142	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—chronic kidney failure	2.13e-05	0.000141	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—FASN—chronic kidney failure	2.13e-05	0.000141	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—chronic kidney failure	2.11e-05	0.000139	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—chronic kidney failure	2.09e-05	0.000138	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SREBF2—chronic kidney failure	2e-05	0.000133	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP3A4—chronic kidney failure	1.97e-05	0.000131	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCA1—chronic kidney failure	1.94e-05	0.000128	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GCKR—chronic kidney failure	1.93e-05	0.000128	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCC3—chronic kidney failure	1.93e-05	0.000128	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LPIN1—chronic kidney failure	1.89e-05	0.000125	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	1.86e-05	0.000123	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LRP2—chronic kidney failure	1.86e-05	0.000123	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CAT—chronic kidney failure	1.64e-05	0.000109	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CPT1A—chronic kidney failure	1.58e-05	0.000104	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LIPC—chronic kidney failure	1.54e-05	0.000102	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	1.54e-05	0.000102	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LPL—chronic kidney failure	1.52e-05	0.000101	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP1A1—chronic kidney failure	1.47e-05	9.73e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SCARB1—chronic kidney failure	1.42e-05	9.39e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS1—chronic kidney failure	1.41e-05	9.3e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SREBF1—chronic kidney failure	1.38e-05	9.12e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTHFR—chronic kidney failure	1.37e-05	9.07e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARA—chronic kidney failure	1.34e-05	8.89e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMGCR—chronic kidney failure	1.34e-05	8.87e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—FASN—chronic kidney failure	1.31e-05	8.68e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCA1—chronic kidney failure	1.2e-05	7.91e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—POMC—chronic kidney failure	1.1e-05	7.25e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CAT—chronic kidney failure	1.01e-05	6.69e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—chronic kidney failure	1e-05	6.61e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCB1—chronic kidney failure	9.84e-06	6.51e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NOS3—chronic kidney failure	9.56e-06	6.32e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LPL—chronic kidney failure	9.38e-06	6.2e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	9.06e-06	5.99e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—chronic kidney failure	8.74e-06	5.78e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTHFR—chronic kidney failure	8.45e-06	5.59e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARA—chronic kidney failure	8.29e-06	5.48e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—POMC—chronic kidney failure	6.75e-06	4.47e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—chronic kidney failure	6.16e-06	4.07e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NOS3—chronic kidney failure	5.89e-06	3.9e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—chronic kidney failure	5.39e-06	3.56e-05	CbGpPWpGaD
